Goldman Sachs analysts : The money men saying the quiet part out loud
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
December 18, 2024 at 10:48 AM
Goldman Sachs analysts : The money men saying the quiet part out loud
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
for some reason the left (goldman sachs) refuses to take AI seriously
AI Added 'Basically Zero' to US Economic Growth Last Year, Goldman Sachs Says https://gizmodo.com/ai-added-basically-zero-to-us-economic-growth-last-year-goldman-sachs-says-2000725380
AI Added 'Basically Zero' to US Economic Growth Last Year, Goldman Sachs Says
Imported chips and hardware mean the AI investemtns are translating into US GDP growth.
gizmodo.com
February 24, 2026 at 4:40 AM
for some reason the left (goldman sachs) refuses to take AI seriously
goldman sachs execs showing up to luigi mangione's cell like nick fury recruiting an avenger
“A top Goldman Sachs executive summed up the frustration with Mr. Trump succinctly: Someone has to stop him.”
www.nytimes.com/2025/04/06/b...
www.nytimes.com/2025/04/06/b...
Wall Street’s Decision Makers Brace for More Chaos After Markets Plunge
The financial titans who backed Trump are now dealing with the fallout from his tariffs. They spent the weekend surveying the damage of last week’s major sell-off.
www.nytimes.com
April 7, 2025 at 3:56 AM
goldman sachs execs showing up to luigi mangione's cell like nick fury recruiting an avenger
Good for Goldman Sachs and also we’re in upside down world
Goldman Sachs
Diversity & Inclusion
Our people are our greatest asset. We believe that a major strength and principal reason for our success is the quality, dedication, determination and collaboration of our people, which enables us to serve our clients, generate long-term value for our shareholders
Diversity & Inclusion
Our people are our greatest asset. We believe that a major strength and principal reason for our success is the quality, dedication, determination and collaboration of our people, which enables us to serve our clients, generate long-term value for our shareholders
April 24, 2025 at 11:26 AM
Good for Goldman Sachs and also we’re in upside down world
JPMorgan and Goldman Sachs are pushing back on demands to roll back their diversity initiatives
JPMorgan, Goldman CEOs Resist Calls to Roll Back DEI Programs
JPMorgan Chase & Co. and Goldman Sachs Group Inc. are pushing back on demands to roll back their diversity initiatives.
www.bloomberg.com
January 22, 2025 at 8:43 PM
JPMorgan and Goldman Sachs are pushing back on demands to roll back their diversity initiatives
also, Jeffrey Sachs
June 9, 2025 at 5:10 AM
also, Jeffrey Sachs
AI Added 'Basically Zero' to US Economic Growth Last Year, Goldman Sachs Says https://gizmodo.com/ai-added-basically-zero-to-us-economic-growth-last-year-goldman-sachs-says-2000725380
AI Added 'Basically Zero' to US Economic Growth Last Year, Goldman Sachs Says
Imported chips and hardware mean the AI investemtns are translating into US GDP growth.
gizmodo.com
February 23, 2026 at 5:45 PM
AI Added 'Basically Zero' to US Economic Growth Last Year, Goldman Sachs Says https://gizmodo.com/ai-added-basically-zero-to-us-economic-growth-last-year-goldman-sachs-says-2000725380
Goldman Sachs and Harvard University, leading the resistance.
💥 BREAKING: Goldman Sachs shareholders voted today to reject two anti-DEI proposals, both by 98-2 percent. GS Board urged shareholders to vote to reject proposals. "We believe that diversity, including diversity of thought, experience and perspectives, is important to our commercial success."
April 23, 2025 at 3:53 PM
Goldman Sachs and Harvard University, leading the resistance.
Reflections...
Bayern © Daniel Sachs
Bayern © Daniel Sachs
September 11, 2024 at 2:26 PM
Reflections...
Bayern © Daniel Sachs
Bayern © Daniel Sachs
This article highlights why more “crazy motherfuckers”are likely going to kill more extremely wealthy, “heartless, motherfuckers.”
Society has reached the tipping point on inequities. Especially those leaving the masses to suffer and die.
www.cnbc.com/2018/04/11/g...
Society has reached the tipping point on inequities. Especially those leaving the masses to suffer and die.
www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
December 18, 2024 at 7:41 AM
This article highlights why more “crazy motherfuckers”are likely going to kill more extremely wealthy, “heartless, motherfuckers.”
Society has reached the tipping point on inequities. Especially those leaving the masses to suffer and die.
www.cnbc.com/2018/04/11/g...
Society has reached the tipping point on inequities. Especially those leaving the masses to suffer and die.
www.cnbc.com/2018/04/11/g...
The greedy psychopaths!
Goldman Sachs: cures could be bad for business in the long run.
“Is curing patients a sustainable business model?” GS analysts ask in an April 10 report entitled “The Genome Revolution.”
www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
January 3, 2025 at 8:28 PM
The greedy psychopaths!
Goldman Sachs: cures could be bad for business in the long run.
“Is curing patients a sustainable business model?” GS analysts ask in an April 10 report entitled “The Genome Revolution.”
www.cnbc.com/2018/04/11/g...
Don't make me like Goldman Sachs.
💥 BREAKING: Goldman Sachs shareholders voted today to reject two anti-DEI proposals, both by 98-2 percent. GS Board urged shareholders to vote to reject proposals. "We believe that diversity, including diversity of thought, experience and perspectives, is important to our commercial success."
April 24, 2025 at 12:54 AM
Don't make me like Goldman Sachs.
Oh look, another Goldman Sachs guy.
Defence Investment Agency CEO Doug Guzman is an investment banker. A capital markets guy. A -- you guessed it -- former Goldman Sachs man.
"Mr. Carney recruited Mr. Guzman, a close personal friend, from the Royal Bank of Canada, where he was deputy chair."
#CdnPoli
"Mr. Carney recruited Mr. Guzman, a close personal friend, from the Royal Bank of Canada, where he was deputy chair."
#CdnPoli
October 5, 2026 at 10:24 PM
Oh look, another Goldman Sachs guy.
So far here’s a list of companies reinforcing their commitment to Diversity, Equity & Inclusion:
Apple
Costco
Bank of America
Delta
JP Morgan
Marriott
Microsoft
Procter & Gamble
Goldman Sachs
American Airlines
Southwest Airlines
United Airlines
Catholic Health
Apple
Costco
Bank of America
Delta
JP Morgan
Marriott
Microsoft
Procter & Gamble
Goldman Sachs
American Airlines
Southwest Airlines
United Airlines
Catholic Health
January 26, 2025 at 9:14 PM
So far here’s a list of companies reinforcing their commitment to Diversity, Equity & Inclusion:
Apple
Costco
Bank of America
Delta
JP Morgan
Marriott
Microsoft
Procter & Gamble
Goldman Sachs
American Airlines
Southwest Airlines
United Airlines
Catholic Health
Apple
Costco
Bank of America
Delta
JP Morgan
Marriott
Microsoft
Procter & Gamble
Goldman Sachs
American Airlines
Southwest Airlines
United Airlines
Catholic Health
Alles ist im Werden, zwinkert der Schmetterling.
Nelly Sachs
Nelly Sachs
April 16, 2026 at 9:54 PM
Alles ist im Werden, zwinkert der Schmetterling.
Nelly Sachs
Nelly Sachs
Goldman Sachs: socialism in one firm
October 2, 2026 at 2:08 PM
Goldman Sachs: socialism in one firm
Goldman Sachs has raised its 12-month U.S. recession probability score to 45%.
April 8, 2025 at 2:15 PM
Goldman Sachs has raised its 12-month U.S. recession probability score to 45%.
BREAKING: Strait of Hormuz now observing New York Stock Exchange hours. Lunch break sponsored by Goldman Sachs.
April 18, 2026 at 5:47 PM
BREAKING: Strait of Hormuz now observing New York Stock Exchange hours. Lunch break sponsored by Goldman Sachs.
Interesting.
January 29, 2025 at 2:54 PM
Interesting.
Goldman Sachs chief says Brexit has left London’s financial status “fragile” as banks move to EU cities
www.thelondoneconomic.com/business-eco...
www.thelondoneconomic.com/business-eco...
Goldman Sachs chief says Brexit has left London’s financial status “fragile” as banks move to EU cities
See how Brexit has negatively impacted London's status as a financial hub, with insights from Goldman Sachs CEO David Solomon.
www.thelondoneconomic.com
July 24, 2025 at 8:47 AM
Goldman Sachs chief says Brexit has left London’s financial status “fragile” as banks move to EU cities
www.thelondoneconomic.com/business-eco...
www.thelondoneconomic.com/business-eco...
Opinion | The US wouldn't have to invade Canada if Canada hadn't threatened to join NATO.
by Jeffrey Sachs
by Jeffrey Sachs
January 12, 2025 at 1:49 AM
Opinion | The US wouldn't have to invade Canada if Canada hadn't threatened to join NATO.
by Jeffrey Sachs
by Jeffrey Sachs
I can hardly think of a better example of the moral decay in modern health care than a Goldman analyst noting that biotech cures for diseases like hepatitis are cool and all, until their success diminishes the business opportunity for pharmaceutical manufacturers.
www.cnbc.com/2018/04/11/g...
www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
December 19, 2024 at 11:57 PM
I can hardly think of a better example of the moral decay in modern health care than a Goldman analyst noting that biotech cures for diseases like hepatitis are cool and all, until their success diminishes the business opportunity for pharmaceutical manufacturers.
www.cnbc.com/2018/04/11/g...
www.cnbc.com/2018/04/11/g...
